Control of collagen production in mouse chondrocytes by using a combination of bone morphogenetic protein-2 and small interfering RNA targeting col1a1 for hydrogel-based tissue-engineered cartilage

Tissue Engineering - Part C: Methods

Volumn 19, Issue 8, 2013, Pages 652-664

  Perrier Groult, Emeline ^a   Pasdeloup, Marielle ^a   Malbouyres, Marilyne ^a   Galéra, Philippe ^b   Mallein Gerin, Frédéric ^a  

^a INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; CARTILAGE; ELECTRON MICROSCOPY; ENZYME INHIBITION; HYDROGELS; MAMMALS; POLYMERASE CHAIN REACTION; PROTEINS; REPAIR; RNA; TISSUE; TISSUE ENGINEERING;

AUTOLOGOUS CHONDROCYTE IMPLANTATIONS; BONE MORPHOGENETIC PROTEIN-2; BONE MORPHOGENETIC PROTEINS; EXTRACELLULAR MATRICES; REAL-TIME POLYMERASE CHAIN REACTION; SMALL INTERFERING RNA (SIRNA); TISSUE ENGINEERED CARTILAGE; TRANSFORMING GROWTH FACTORS;

BODY FLUIDS;

BMP2 PROTEIN, MOUSE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; COLLAGEN TYPE I, ALPHA 1 CHAIN; MESSENGER RNA; SMALL INTERFERING RNA; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA1; HYDROGEL;

ANIMAL; ARTICLE; BIOSYNTHESIS; CARTILAGE CELL; CELL CULTURE; CHEMISTRY; CYTOLOGY; EXTRACELLULAR MATRIX; GENETICS; HYALINE CARTILAGE; HYDROGEL; METABOLISM; MOUSE; REAL TIME POLYMERASE CHAIN REACTION; TIME; TISSUE ENGINEERING;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; HYALINE CARTILAGE; HYDROGELS; MICE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84879406286     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2012.0396     Document Type: Article

References (48)

1. von der Mark, K., Gauss, V., von der Mark, H., and Muller, P. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 267, 531, 1977.
2. Schindler, O.S. Current concepts of articular cartilage repair. Acta Orthop Belg 77, 709, 2011.
3. Bougault, C., Paumier, A., Aubert-Foucher, E., and Mallein-Gerin, F. Molecular analysis of chondrocytes cultured in agarose in response to dynamic compression. BMC Bio-technol 8, 71, 2008.
4. Bougault, C., Paumier, A., Aubert-Foucher, E., and Mallein-Gerin, F. Investigating conversion of mechanical force into biochemical signaling in three-dimensional chondrocyte cultures. Nat Protoc 4, 928, 2009.
5. Gouttenoire, J., Bougault, C., Aubert-Foucher, E., Perrier, E., Ronziere, M.C., Sandell, L., et al. BMP-2 and TGF-beta1 differentially control expression of type II procollagen and alpha 10 and alpha 11 integrins in mouse chondrocytes. Eur J Cell Biol 89, 307, 2010.
6. Gouttenoire, J., Valcourt, U., Bougault, C., Aubert-Foucher, E., Arnaud, E., Giraud, L., et al. Knockdown of the intra-flagellar transport protein IFT46 stimulates selective gene expression in mouse chondrocytes and affects early development in zebrafish. J Biol Chem 282, 30960, 2007.
7. Valcourt, U., Gouttenoire, J., Aubert-Foucher, E., Herbage, D., and Mallein-Gerin, F. Alternative splicing of type II procollagen pre-mRNA in chondrocytes is oppositely regulated by BMP-2 and TGF-beta1. FEBS Lett 545, 115, 2003.
8. Valcourt, U., Gouttenoire, J., Moustakas, A., Herbage, D., and Mallein-Gerin, F. Functions of transforming growth factor-beta family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes. J Biol Chem 277, 33545, 2002.
9. Claus, S., Aubert-Foucher, E., Demoor, M., Camuzeaux, B., Paumier, A., Piperno, M., et al. Chronic exposure of bone morphogenetic protein-2 favors chondrogenic expression in human articular chondrocytes amplified in monolayer cultures. J Cell Biochem 111, 1642, 2010.
10. Hautier, A., Salentey, V., Aubert-Foucher, E., Bougault, C., Beauchef, G., Ronziere, M.C., et al. Bone morphogenetic protein-2 stimulates chondrogenic expression in human nasal chondrocytes expanded in vitro. Growth Factors 26, 201, 2008.
11. Marlovits, S., Hombauer, M., Truppe, M., Vecsei, V., and Schlegel, W. Changes in the ratio of type-I and type-II collagen expression during monolayer culture of human chondrocytes. J Bone Joint Surg Br 86, 286, 2004.
12. Darling, E.M., and Athanasiou, K.A. Growth factor impact on articular cartilage subpopulations. Cell Tissue Res 322, 463, 2005.
13. Narcisi, R., Quarto, R., Ulivi, V., Muraglia, A., Molfetta, L., and Giannoni, P. TGF beta-1 administration during ex-vivo expansion of human articular chondrocytes in a serum-free medium redirects the cell phenotype toward hypertrophy. J Cell Physiol, 227, 3282, 2011.
14. Lefebvre, V., Garofalo, S., Zhou, G., Metsaranta, M., Vuorio, E., and De Crombrugghe, B. Characterization of primary cultures of chondrocytes from type II collagen/beta-galac-tosidase transgenic mice. Matrix Biol 14, 329, 1994.
15. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45, 2001.
16. Claus, S., Mayer, N., Aubert-Foucher, E., Chajra, H., Perrier-Groult, E., Lafont, J., et al. Cartilage-characteristic matrix reconstruction by sequential addition of soluble factors during expansion of human articular chondrocytes and their cultivation in collagen sponges. Tissue Eng Part C Methods 18, 104, 2012.
17. Mallein-Gerin, F., Ruggiero, F., Quinn, T.M., Bard, F., Grodzinsky, A.J., Olsen, B.R., et al. Analysis of collagen synthesis and assembly in culture by immortalized mouse chondrocytes in the presence or absence of alpha 1(IX) collagen chains. Exp Cell Res 219, 257, 1995.
18. Schmid, T.M., and Linsenmayer, T.F. Immunohistochemical localization of short chain cartilage collagen (type X) in avian tissues. J Cell Biol 100, 598, 1985.
19. Bruckner, P., Mendler, M., Steinmann, B., Huber, S., and Winterhalter, K.H. The structure of human collagen type IX and its organization in fetal and infant cartilage fibrils. J Biol Chem 263, 16911, 1988.
20. Lefebvre, V., Huang, W., Harley, V.R., Goodfellow, P.N., and de Crombrugghe, B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17, 2336, 1997.
21. Poole, C.A., Flint, M.H., and Beaumont, B.W. Chondrons in cartilage: ultrastructural analysis of the pericellular micro-environment in adult human articular cartilages. J Orthop Res 5, 509, 1987.
22. Canty, E.G., and Kadler, K.E. Procollagen trafficking, processing and fibrillogenesis. J Cell Sci 118, 1341, 2005.
23. Stewart, M.C., Saunders, K.M., Burton-Wurster, N., and Macleod, J.N. Phenotypic stability of articular chondrocytes in vitro: the effects of culture models, bone morphogenetic protein 2, and serum supplementation. J Bone Miner Res 15, 166, 2000.
24. Millington-Ward, S., McMahon, H.P., Allen, D., Tuohy, G., Kiang, A.S., Palfi, A., et al. RNAi of COL1A1 in mesenchy-mal progenitor cells. Eur J Hum Genet 12, 864, 2004.
25. Wang, Q., Peng, Z., Xiao, S., Geng, S., Yuan, J., and Li, Z. RNAi-mediated inhibition of COL1A1 and COL3A1 in human skin fibroblasts. Exp Dermatol 16, 611, 2007.
26. Yao, Y., Zhang, F., Pang, P.X., Su, K., Zhou, R., Wang, Y., et al. In vitro study of chondrocyte redifferentiation with lentiviral vector-mediated transgenic TGF-beta3 and shRNA suppressing type I collagen in three-dimensional culture. J Tissue Eng Regen Med 5, e219, 2011.
27. Yao, Y., Zhang, F., Zhou, R., Su, K., Fan, J., and Wang, D.A. Effects of combinational adenoviral vector-mediated TGF beta 3 transgene and shRNA silencing type I collagen on articular chondrogenesis of synovium-derived mesenchymal stem cells. Biotechnol Bioeng 106, 818, 2010.
28. Han, S., Makareeva, E., Kuznetsova, N.V., DeRidder, A.M., Sutter, M.B., Losert, W., et al. Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases. J Biol Chem 285, 22276, 2010.
29. Han, S., McBride, D.J., Losert, W., and Leikin, S. Segregation of type I collagen homo-and heterotrimers in fibrils. J Mol Biol 383, 122, 2008.
30. Jimenez, S.A., Bashey, R.I., Benditt, M., and Yankowski, R. Identification of collagen alpha1(I) trimer in embryonic chick tendons and calvaria. Biochem Biophys Res Commun 78, 1354, 1977.
31. Moro, L., and Smith, B.D. Identification of collagen al-pha1(I) trimer and normal type I collagen in a polyoma virus-induced mouse tumor. Arch Biochem Biophys 182, 33, 1977.
32. Buschmann, M.D., Gluzband, Y.A., Grodzinsky, A.J., Ki-mura, J.H., and Hunziker, E.B. Chondrocytes in agarose culture synthesize a mechanically functional extracellular matrix. J Orthop Res 10, 745, 1992.
33. Mauck, R.L., Soltz, M.A., Wang, C.C., Wong, D.D., Chao, P.H., Valhmu, W.B., et al. Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-seeded agarose gels. J Biomech Eng 122, 252, 2000.
34. Benya, P.D., and Shaffer, J.D. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30, 215, 1982.
35. Govender, S., Csimma, C., Genant, H.K., Valentin-Opran, A., Amit, Y., Arbel, R., et al. Recombinant human bone mor-phogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A, 2123, 2002.
36. Landry, Y., and Gies, J.P. Drugs and their molecular targets: an updated overview. Fundam Clin Pharmacol 22, 1, 2008.
37. Barlic, A., Drobnic, M., Malicev, E., and Kregar-Velikonja, N. Quantitative analysis of gene expression in human articular chondrocytes assigned for autologous implantation. J Or-thop Res 26, 847, 2008.
38. Selmi, T.A., Verdonk, P., Chambat, P., Dubrana, F., Potel, J.F., Barnouin, L., et al. Autologous chondrocyte implantation in a novel alginate-agarose hydrogel: outcome at two years. J Bone Joint Surg Br 90, 597, 2008.
39. Wang, Z., Rao, D.D., Senzer, N., and Nemunaitis, J. RNA interference and cancer therapy. Pharm Res 28, 2983, 2011.
40. de Franca, N.R., Mesquita Junior, D., Lima, A.B., Pucci, F.V., Andrade, L.E., and Silva, N.P. RNA interference: a new alternative for rheumatic diseases therapy. Rev Bras Reumatol 50, 695, 2010.
41. Huber, L.C., Distler, O., Gay, R.E., and Gay, S. Antisense strategies in degenerative joint diseases: sense or nonsense? Adv Drug Deliv Rev 58, 285, 2006.
42. Salvat, C., Pigenet, A., Humbert, L., Berenbaum, F., and Thirion, S. Immature murine articular chondrocytes in primary culture: a new tool for investigating cartilage. Os-teoarthritis Cartilage 13, 243, 2005.
43. Cormier, S.A., Mello, M.A., and Kappen, C. Normal proliferation and differentiation of Hoxc-8 transgenic chon-drocytes in vitro. BMC Dev Biol 3, 4, 2003.
44. Huang, Z., Xu, H., and Sandell, L. Negative regulation of chondrocyte differentiation by transcription factor AP-2alpha. J Bone Miner Res 19, 245, 2004.
45. Valcourt, U., Ronziere, M.C., Winkler, P., Rosen, V., Herbage, D., and Mallein-Gerin, F. Different effects of bone morphogenetic proteins 2, 4, 12, and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line. Exp Cell Res 251, 264, 1999.
46. Mayne, R., Mayne, P.M., Ren, Z., Accavitti, M.A., Gur-usiddappa, S., and Scott, P.G. Monoclonal antibody to the aminotelopeptide of type II collagen: loss of the epitope after stromelysin digestion. Connect Tissue Res 31, 11, 1994.
47. Oganesian, A., Zhu, Y., and Sandell, L.J. Type IIA pro-collagen amino propeptide is localized in human embryonic tissues. J Histochem Cytochem 45, 1469, 1997.
48. Warman, M., Kimura, T., Muragaki, Y., Castagnola, P., Ta-mei, H., Iwata, K., et al. Monoclonal antibodies against two epitopes in the human alpha 1 (IX) collagen chain. Matrix 13, 149, 1993.